NCLT approves Dhanuka Lab’s Rs 1,116 crore plan to buy debt-hit Orchid Pharma

A consortium of 24 banks has lent a total of over Rs 3,200 crore to
the drug maker and the lenders will be taking a haircut of around 65%.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nclt-approves-dhanuka-labs-rs-1116-crore-plan-to-buy-debt-hit-orchid-pharma/articleshow/69950982.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation